We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App





Siemens Highlights Presents Latest Breakthroughs in Healthcare

By LabMedica International staff writers
Posted on 03 Feb 2025
Print article
Image: Laboratories can experience integrated automation in 6m2 on the Atellica Solution (Photo courtesy of Siemens)
Image: Laboratories can experience integrated automation in 6m2 on the Atellica Solution (Photo courtesy of Siemens)

Siemens Healthineers (Forchheim, Germany) is presenting its transformative healthcare solutions at Medlab Middle East 2025 that are designed to empower professionals to provide the highest level of care to their patients.

Siemens is highlighting various products highlighted including its two new high-volume hematology analyzers, the Atellica HEMA 570 and 580. Designed to meet the hematology testing needs of today’s high-volume labs, both instruments share fast throughput and an identical footprint. Also featured at the event is the IMMULITE 2000 XPi immunoassay system that provides multiple tests on a single, easy-to-use analyzer. This makes it simple to adjust to changes in demand and scale capabilities without disrupting day-to-day operations. Additionally, Siemens is presenting the CN-3000 and CN-6000 coagulation designed to meet the small-sized, mid- and high-volume hemostasis testing solutions. The CN Systems leverage optical testing methodology with intelligent software to automate and standardize sample management for reliable results, reduced repeat testing, and reagent waste. Siemens is also highlighting Atellica Integrated Automation which consolidates revolutionary sample management technology, intelligent software, and IT to provide workflow efficiency with the flexibility to add decapping with little or no additional footprint.

Among its compact solutions featured at the event is the Atellica DCA Analyzer which puts fast, quality HbA1c and ACR results right at the fingertips. Experience the performance and precision you need to improve outcomes. Designed with the speed, standardization, and personalization required to boost efficiencies and meet growing demand, the Atellica DCA Analyzer can be placed wherever it is needed when space is at a premium. Also featured at the event is the RAPIDPoint 500e System that elevates Siemens’ blood gas offering to a new level. This end-to-end blood gas solution reduces the daily burden of device management and enables healthcare professionals to give full care and attention to their patients. Moreover, Siemens is also demonstrating the Atellica VTLi patient-side immunoassay analyzer for high-sensitivity troponin testing at the point of care. It produces accurate results in just 8 minutes, improving ED throughput, reducing stress and strain on acute care clinicians, and aiding in optimizing the use of time and resources of busy laboratories.

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Biological Indicator Vials
BI-O.K.
New
Auto Clinical Chemistry Analyzer
cobas c 703

Print article

Channels

Clinical Chemistry

view channel
Image: The research team has developed the uCR-Chip device to enhance kidney function testing (Photo courtesy of University of Manitoba)

Low-Cost Portable Screening Test to Transform Kidney Disease Detection

Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.